The Home Testing Boom: What Changed, and What to Make of It

Before 2020, home diagnostic testing in the United States meant three things: pregnancy tests, blood glucose meters for people with diabetes, and the occasional drug screen. Everything else happened in a clinic or a lab.

Then several hundred million people ran a nasal swab on themselves at a kitchen table, read the result, and acted on it. The experience did not go away when the emergency did. It changed what people expect to be able to do at home, and it changed what companies build.

What the category looks like now

Walk the pharmacy aisle or search online and the range is wide.

Infection tests. COVID, flu, strep, UTI, HIV, and combinations. Rapid antigen and, increasingly, molecular tests that run on small home devices.

Metabolic markers. Blood glucose meters, continuous glucose monitors sold without a prescription, home A1C kits, cholesterol meters, ketone strips.

Urine chemistry. Ten parameter dipsticks, pH strips, ketone strips, microalbumin and uACR kits for kidney monitoring, and app read versions that use a phone camera in place of the eye.

Screening kits. Stool tests for colorectal cancer screening, HPV self collection now approved in the US, and mail in blood tests for dozens of markers.

Monitors. Validated blood pressure cuffs, pulse oximeters, ECG patches, and wearables that estimate an expanding list of things with varying accuracy.

What the regulator changed

The FDA's approach shifted in three ways.

First, it cleared or authorized far more tests for over the counter use, meaning use by an untrained person without a prescription. Before 2020 that category was small. The emergency use pathway for COVID tests established that lay users could run and read a test reliably when the instructions were good, and that evidence carried over to other products.

Second, it began treating phone apps that read tests as part of the device. An app that interprets a urine strip photograph is now reviewed with the strip, with performance data required for the combination, not just the chemistry. See how phone apps read urine test strips.

Third, in 2024 it finalized a rule bringing laboratory developed tests, including many mail in kits, under device regulation, a change that was later partly rolled back in the courts. The practical effect is that the labels on home and mail in tests are in flux. The terms that matter are explained in where to buy urine test strips, and they apply to every category.

What got better

Access. A person with diabetes or hypertension can now run the yearly kidney albumin test guidelines recommend without a separate clinic visit, which is the visit that usually did not happen. See why kidney disease is found late.

Frequency. A once a year lab number becomes a monthly home number. Trends appear that a single reading would never show.

Readability. App read tests removed the color matching step that made home strips unreliable. Validated cuffs with averaging removed the single reading problem.

Cost per data point. Cents for a strip, a few dollars for a fingerstick, versus a visit and a lab bill.

What did not get better, or got worse

Interpretation. More results reach people who have never been taught what a false positive is. The arithmetic of base rates, explained in how to use home health tests without fooling yourself, has not changed. What changed is how many people are now on the wrong side of it.

Scope creep. Tests validated for one purpose get marketed for another. Continuous glucose monitors built for insulin dosing are sold as wellness gadgets to people with normal glucose. Urine strips cleared for screening are described as if they diagnose.

Unregulated products next to regulated ones. The same search returns a cleared over the counter kit and a "research use only" strip in a plain bottle. They look alike. They are not.

The confirmation gap. A home positive is supposed to lead to a confirmatory test and a clinician. Often it leads to a second home test, then a third, then nothing. Or to the opposite: a visit for a result that a repeat under better conditions would have cleared.

How to be a good customer of it

Test for a reason, not because a kit exists. Buy cleared products and read the intended use. Learn the miss rate of the test you are holding before you trust a negative. Repeat under good conditions before you act on a positive. Write results down with a date and a time. Treat every meaningful result as the start of a conversation with a clinician, not the end of one.

None of that is complicated. It is also not on the box. That gap is the reason this site exists, and every guide on Ribbon Checkup is written to close some part of it.